Pertuzumab

Generic name: Pertuzumab
Brand names: Perjeta
Dosage form: intravenous solution (420 mg/14 mL)
Drug class: HER2 inhibitors

Usage of Pertuzumab

Pertuzumab is used together with other medicines (trastuzumab and docetaxel) to treat HER2-positive breast cancer.

Pertuzumab may also be used for purposes not listed in this medication guide.

Pertuzumab side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your caregiver right away if you feel weak, tired, or nauseated, or if you have a fast heartbeat, headache, fever, chills, muscle pain, or an unusual taste in your mouth.

Pertuzumab may cause serious side effects. Call your doctor at once if you have:

dizziness, pounding heartbeats or fluttering in your chest;

new or worsening cough or shortness of breath;

swelling in your lower legs;

low blood cell counts--fever, chills, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed; or

signs of tumor cell breakdown--confusion, weakness, muscle cramps, nausea, vomiting, fast or slow heart rate, decreased urination, tingling in your hands and feet or around your mouth.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects are more likely to occur, such as:

nausea, diarrhea;

temporary hair loss;

fever, low blood cell counts;

tiredness;

rash; or

numbness, tingling, or burning pain in your hands or feet.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Pertuzumab

You should not use pertuzumab if you are allergic to it, or if you are pregnant or breast-feeding.

Tell your doctor if you have ever had:

heart disease, congestive heart failure, heart rhythm disorder;

untreated or uncontrolled high blood pressure (hypertension);

a heart attack; or

radiation treatment in your chest area.

Do not use pertuzumab if you are pregnant. It can cause birth defects or death to the unborn baby. Use effective birth control to prevent pregnancy while you are using pertuzumab with trastuzumab, and for at least 7 months after your treatment ends. Tell your doctor right away if you become pregnant.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of pertuzumab on the baby.

It may not be safe to breastfeed while using pertuzumab with trastuzumab, and for up to 7 months after your last dose. Ask your doctor about any risk.

Relate drugs

How to use Pertuzumab

Pertuzumab is given as an infusion into a vein. A healthcare provider will give you this injection.

Pertuzumab is usually given once every 3 weeks. Follow your doctor's instructions.

Pertuzumab can cause life-threatening heart problems. Your heart function may need to be checked before you start using pertuzumab and during your treatment.

Warnings

Pertuzumab can cause birth defects or death to the unborn baby. Do not use if you are pregnant. Avoid getting pregnant while using pertuzumab and for at least 7 months after your last dose.

Pertuzumab can cause life-threatening heart problems. Call your doctor at once if you have new or worsening cough, shortness of breath, or swelling in your lower legs.

What other drugs will affect Pertuzumab

Other drugs may affect pertuzumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.